SCENIC BIOTECH
Scenic Biotech is a developer of a genomics and immunotherapy technologies created to unlock genetic suppressors as a new class of drug targets.The company's immunotherapy technologies tackle diseases on the genetic level and focuses on disease suppressing genes., it uses genomics to develop innovative therapies for patients affected by severe diseases.
SCENIC BIOTECH
Social Links:
Industry:
Biometrics Biotechnology Collaborative Consumption Life Science
Founded:
2017-01-01
Address:
Amsterdam, Noord-Holland, The Netherlands
Country:
The Netherlands
Website Url:
http://www.scenicbiotech.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
37.6 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Google Tag Manager WordPress Content Delivery Network Google Universal Analytics
Similar Organizations
Bright Peak Therapeutics
Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases.
Cerevance
Cerevance is a developer of novel therapeutics intended to advance new medicines for serious neurological diseases.
EnteroBiotix
EnteroBiotix is a developer of novel medicinal products intended to restore health and prevent bacterial infections.
Gracell Biotechnologies
Gracell Biotechnologies is a developer of cancer immune therapy designed to treat cancer.
ONI
ONI is a pioneer of super-resolution microscopy, making this advanced technology accessible to new generations of researchers.
SpyBiotech
SpyBiotech Operators of a biotechnology platform intended to generate next-generation vaccines.
Current Advisors List
Current Employees Featured
Founder
Investors List
BioGeneration Ventures
BioGeneration Ventures investment in Series A - Scenic Biotech
Inkef
Inkef investment in Series A - Scenic Biotech
Oxford Science Enterprises
Oxford Science Enterprises investment in Series A - Scenic Biotech
EIR Ventures
EIR Ventures investment in Series A - Scenic Biotech
Vesalius Biocapital Partners
Vesalius Biocapital Partners investment in Series A - Scenic Biotech
BioMedPartners
BioMedPartners investment in Series A - Scenic Biotech
Netherlands Enterprise Agency
Netherlands Enterprise Agency investment in Grant - Scenic Biotech
Oxford University Innovation
Oxford University Innovation investment in Series A - Scenic Biotech
BioGeneration Ventures
BioGeneration Ventures investment in Series A - Scenic Biotech
Oxford Science Enterprises
Oxford Science Enterprises investment in Series A - Scenic Biotech
Official Site Inspections
http://www.scenicbiotech.com Semrush global rank: 6.8 M Semrush visits lastest month: 783
- Host name: server024.yourhosting.nl
- IP address: 185.37.71.31
- Location: Netherlands
- Latitude: 52.3824
- Longitude: 4.8995
- Timezone: Europe/Amsterdam
More informations about "Scenic Biotech"
About - Scenic Biotech
Alexander began his career at McKinsey & Co. in 1989 after which he joined Genzyme Europe in 1994. At Genzyme, he held several executive roles, including leading a global joint venture โฆSee details»
Scenic Biotech - Crunchbase Company Profile & Funding
Contact Email [email protected] Scenic Biotech is a developer of a genomics and immunotherapy technologies created to unlock genetic โฆSee details»
Scenic Biotech B.V. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Scenic Biotech B.V. of Amsterdam, Noord-Holland. Get the latest business insights from Dun & Bradstreet.See details»
Scenic Biotech 2025 Company Profile: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for Scenic Biotech. Use the PitchBook Platform to explore the full profile.See details»
Scenic Biotech - LinkedIn
Scenic Biotech is advancing modifier therapy, a radically new approach to treating genetic disorders. Instead of targeting the primary disease-causing mutation, modifier therapy seeks to rebalance ...See details»
Scenic Biotech - Oxford Science Enterprises
Latest News All Company News 09โข12โข23 Portfolio News Scenic Biotech Announces Positive Preclinical Data for its QPCTL Inhibitor SC-2882 01โข02โข23 Portfolio News Scenic Biotech enters cooperative research and development โฆSee details»
Scenic Biotech B.V. - BioCentury Company Profiles - BCIQ
Feb 27, 2025 Scenic Biotech B.V. - BioCentury Company Profiles for the biopharma industrySee details»
Scenic Biotech BV (Scenic Biotech BV) - ่ฏ็ฉ็ฎก็บฟ_ไธๅฉ_ไธดๅบ่ฏ้ช_ โฆ
View source version on businesswire.com: Contacts Scenic Biotech Oscar Izeboud, PhD, CEO Phone: +31 20 7059 990 Email: [email protected] Trophic Communications Desmond โฆSee details»
Scenic Biotech - Matrix
At Scenic, we specialize in evolution inspired medicine for rare diseases. We are pioneering the field of genetic modifiers for rare genetic diseases.See details»
Scenic Biotech - Craft
Scenic Biotech has 1 employees at their 1 location and $7.33 m in total funding,. See insights on Scenic Biotech including office locations, competitors, revenue, financials, executives, โฆSee details»
Scenic Biotech Company Information - Funding, Investors, and More
Get information on funding, investors, industries, and more for Scenic Biotech. See Scenic Biotech company profile and funding data.See details»
Pipeline - Scenic Biotech
Please contact our Business Development representatives in the US or Europe or write us at [email protected]. Questions about our pipeline? We are always interested to โฆSee details»
Scenic Biotech | EU-Startups
Articles about Scenic Biotech: June 14, 2023 74 Top Biotechnology Startups and Companies in The Netherlands (2021); March 11, 2022 Weekly VC Overview: All European startup funding โฆSee details»
Scenic Biotech Announces $31 Million Financing to Progress โฆ
[email protected] Media Enquiries Sue Charles, Charles Consultants, [email protected] +44 (0)7986 726585 For Eir Ventures Stephan Christgau โฆSee details»
Scenic Biotech Announces $31 Million Financing to Progress โฆ
Mar 10, 2022 Investment will accelerate Scenic Biotechโs transition into a development stage company, advancing its in-house pipeline and supporting the creation of new programs based โฆSee details»
Scenic Bio raises $31m for genetic modifier platform
Mar 10, 2022 18 months after signing its first partnering deal with Genentech, Scenic Biotech has raised $31 million in first-round financing that it will use to take its own genetic modifier โฆSee details»
Harnessing Genetic Suppression to Treat Rare Disease
Feb 5, 2020 Through quirks of genetics, some people are naturally resilient to heritable diseases. Thijn Brummelkamp, Managing Director and co-founder of Scenic Biotech, explains โฆSee details»
Scenic Biotech Announces $31 Million Financing to Progress โฆ
AMSTERDAM, March 10, 2022 /PRNewswire/ -- Scenic Biotech BV ("Scenic"), a pioneer in the discovery of genetic modifiers to enable the development of disease modifying therapeutics for โฆSee details»
SickScience Is Biohacking Beauty With Vegan Exosomes - Forbes
4 days ago Biotech beauty brand SickScience is pushing the industry forward with cutting-edge technology that is clinically proven to quickly deliver results.See details»
Scenic Biotech Enters into Genetic Modifier Collaboration with ...
Sep 21, 2020 Multi-year strategic collaboration in target discovery and therapeutic development based on Scenic Biotechโs disease modifying approach Utilises Scenicโs unique Cell-Seq โฆSee details»